https://www.selleckchem.com/pr....oducts/pf-3758309.ht
Adherence at baseline was a significant predictor of adherence post-intervention in the antidiabetic (OR = 6.5;P 0.0001) and antihypertensive (OR = 4.1; P = 0.0001 β = 0.09; P = 0.008) users. Physician specialty (OR = 3.902; P = 0.01 β = 0.09; P = 0.015) among antidiabetic users and age 70 years (OR = 2.148; P = 0.025) among antihypertensive users were predictors of adherence. The intervention targeting statin did not significantly improve antihypertensive/antidiabetic adherence. Targeted interventions tailored to
Like
Comment
Share
